ABT - Abbott Laboratories

Abbott Laboratories (NYSE:ABT)

Affiliate Disclosure

For more than 130 years, Abbott Laboratories has put science and innovation to work to create more possibilities for more people through the power of health. They understand that the first step to living your best life is good health. 

From removing the regular pain of finger sticks as people manage their diabetes to connecting patients to doctors with real-time information monitoring their hearts, from easing chronic pain and movement disorders to testing half the world’s blood donations to ensure a healthy supply, Abbott’s purpose is to make the world a better place by bringing life-changing health technologies to the people who need them.

Abbott creates breakthrough products – in diagnostics, medical devices, nutrition and branded generic pharmaceuticals – that help individuals, their families and their community lead healthier lives, full of unlimited possibilities. Today, 113,000 employees are working to make a lasting impact on health in the more than 160 countries they serve. Their balanced leadership across diverse markets and geographies gives them more ways to grow and insulates them from the impact of global economic swings, helping them deliver consistent growth and strong shareholder returns, even in an environment as turbulent as today’s.

Focusing solely on cutting-edge innovations alone won't be enough. Their 2030 Sustainability Plan is focused on designing access and affordability into their life-changing technologies and products. Their goal is to improve the lives of more than 3 billion people by decade's end – reaching 1 billion more than they do today, each year. That will require innovating for access and affordability from the first day of research and development. They also are working across their business and in partnership with others to break down barriers and bring these innovations to the people who need them.

Abbott Laboratories Stock Details

  • Ticker: nyse:abt
  • Sector: Healthcare
  • Industry: Medical Devices
  • Market Cap: 195.23B
  • Market Cap Group: Large Cap
  • P/E: 18.96
  • Dividend Yield: 1.69%

ABT Industry Competitors

The competitive landscape is important as they compete for the same business. Below is the list of competitors in the same industry. While not displayed, a number of metrics you can also use to evaluate your picks are the Chowder Score, the Relative Strength Index (RSI), the Graham Number, and the Piotroski F-Score.

Ticker Ticker Company Market Cap P/E Yield Aristocrat Graph SectorID IndustryID
ABT NYSE:ABT Abbott Laboratories 195.23 18.96 1.69 YES 1 8 63
MDT NYSE:MDT Medtronics 125.99 16.87 2.87 YES 1 8 63
SYK NYSE:SYK Stryker Corporation 84.41 24.44 1.25 NO 1 8 63

Top Picks by Bay Street Experts

Expert stock analysts have shared their opinions, and sometimes prediction, on the company.

For more top picks from stock analysts on Bay Street, check the full list of top picks by expect stock analysts from investment and asset management firms.

Not all analysts are equal and they don't cover the same type of stocks. The analysts performance and ownership is tracked for comparison.


Use A Winning Investment Strategy

My portfolio is generating over 12% annual returns since 2009. It's not from the beginning of the year or from 2019, it's from 2009 !!! That's a consistent return which means using the rule of 72, I double my portfolio every 6 years.

My approach is simple but you need key data that I have cultivated with the Dividend Snapshot Screeners. No other investment services provide you with easy to understand data but also actionable data. No hidden magic.

In fact, I have tried all of the investment services for dividend investors like a crash test dummy of investment services. Just ask me, and you'll learn why there was nothing I could use out there and that's how the Dividend Snapshot Screeners were borned!

DISCLOSURE: Please note that I may have a position in one or many of the holdings listed. For a complete list of my holdings, please see my Dividend Portfolio.

DISCLAIMER: Please note that this blog post represents my opinion and not an advice/recommendation. I am not a financial adviser, I am not qualified to give financial advice. Before you buy any stocks/funds consult with a qualified financial planner. Make your investment decisions at your own risk – see my full disclaimer for more details.